Form EFFECT bioAffinity Technologies
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 16, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- bioAffinity Technologies prices $3.2 million public offering
- MustGrow Increases Non-Brokered LIFE Offering to Approximately $3.7 Million
- Prolon Launches Almost Forever, a New Podcast Bridging the Gap Between Longevity Science and Everyday Life
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share